Cargando…
Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance
BACKGROUND: Microthrombosis is a hallmark of COVID-19. We previously described von willebrand factor (VWF) and their high molecular weight multimers (HMWMs) as potential trigger of microthrombosis. OBJECTIVES: Investigate VWF activity with collagen-binding assay and ADAMTS13 in COVID-19. METHODS AND...
Autores principales: | Philippe, Aurélien, Gendron, Nicolas, Bory, Olivier, Beauvais, Agathe, Mirault, Tristan, Planquette, Benjamin, Sanchez, Olivier, Diehl, Jean-Luc, Chocron, Richard, Smadja, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111656/ https://www.ncbi.nlm.nih.gov/pubmed/33974165 http://dx.doi.org/10.1007/s10456-021-09789-3 |
Ejemplares similares
-
Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality
por: Philippe, Aurélien, et al.
Publicado: (2021) -
Fibrin monomers evaluation during hospitalization for COVID-19 is a predictive marker of in-hospital mortality
por: Smadja, David M., et al.
Publicado: (2023) -
Comorbidities associated with higher von Willebrand factor (VWF) levels may explain the age‐related increase of VWF in von Willebrand disease
por: Atiq, Ferdows, et al.
Publicado: (2018) -
Imbalance between alpha-1-antitrypsin and interleukin 6 is associated with in-hospital mortality and thrombosis during COVID-19
por: Philippe, Aurélien, et al.
Publicado: (2022) -
In Vitro Assessment of von Willebrand Factor in Cryoprecipitate,
Antihemophilic Factor/VWF Complex (Human), and Recombinant von Willebrand
Factor
por: Colling, Meaghan E., et al.
Publicado: (2019)